HIV Disease Clinical Trial
Official title:
A 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected Subjects
This study is an observational, cohort, prospective study looking at the frequency of Herpes Simplex Virus (HSV) 1 and or 2 outbreaks in HIV positive patients who's HIV virus is controlled on highly active anti-retroviral therapy. We will be enrolling fifty (50) patients.
We will be confirming that the patients are HIV positive and has antibodies to either HSV 1 or HSV 2 as part of the screening process. If so, we will then obtain patient baseline HIV-PCR, CD4, medial history including medications on day one. Whether the patient is on any or no herpes controlling medication. If the patient has what they feel is a flare up of HSV, they will come into clinic where the lesion will be culture and the patient's HIV-PCR and CD4 will also be obtained. Otherwise, the patient will receive phone follow ups every three months to see if there has been and change in their health or medications. The main endpoint is to see if there is a correlation between outbreaks in HIV patients and their CD4 cells and/or HIV and/or Herpes medication. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03669939 -
Toward Safer Opioid Prescribing for Chronic Pain in High Risk Populations
|
||
| Completed |
NCT02850276 -
Autonomic Neuropathy, GI Motility, and Inflammation in HIV
|
Early Phase 1 | |
| Completed |
NCT01997008 -
Optimizing Resilience and Coping in HIV Via Internet Delivery
|
N/A | |
| Terminated |
NCT01338025 -
Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy
|
Phase 4 | |
| Completed |
NCT01929759 -
Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy and Switch to an Elvitegravir-based Regimen
|
N/A | |
| Completed |
NCT01370018 -
Therapy to Elevate CD4 Counts in HIV-1 Disease
|
Phase 2/Phase 3 | |
| Terminated |
NCT01731691 -
Safety and Efficacy of (α1Proteinase Inhibitor, α1PI) in HIV Disease
|
Phase 2/Phase 3 | |
| Completed |
NCT01656070 -
Vitamin D Supplementation in HIV-infected Youth
|
Phase 2 | |
| Completed |
NCT02090634 -
Texting to Improve Adherence in HIV+ With Bipolar Disorder
|
N/A |